Mini-Reviews in Medicinal Chemistry 2009-01-01

Prodrug designing of NSAIDs.

Parmeshwari K Halen, Prashant R Murumkar, Rajani Giridhar, Mange Ram Yadav

Index: Mini Rev. Med. Chem. 9(1) , 124-39, (2009)

Full Text: HTML

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs), commonly used for the treatment of chronic inflammatory diseases suffer from several undesired side effects, the most important being gastrointestinal (GI) irritation and ulceration. The prodrug designing is one of the several strategies used to overcome this drawback. The rationale behind the prodrug concept is to achieve temporary blockade of the free carboxylic group present in the NSAIDs till their systemic absorption. In this paper, a review on the concept of prodrugs designing of NSAIDs to improve their efficacy and reduce the toxicity is being presented.

Related Compounds

  • glycolamide

Related Articles:

Isolation of amidase-negative mutants of Pseudomonas aeruginosa using glycollamide as a selective agent.

1987-06-01

[J. Gen. Microbiol. 133(6) , 1527-33, (1987)]

Extraction capacity of diglycolamide derivatives for Ca(II), Nd(III) and Zr(IV) from nitric acid to N-dodecane containing a solvent modifier.

2005-10-01

[Anal. Sci. 21(10) , 1171-5, (2005)]

Synthesis and evaluation ofin vitroanti-tuberculosis activity ofN-substituted glycolamides

2009-01-01

[Eur. J. Med. Chem. 44(1) , 289-95, (2009)]

Activity profile of glycolamide ester prodrugs of ibuprofen.

2001-01-01

[Drug Dev. Ind. Pharm. 27(1) , 63-70, (2001)]

A QSAR approach for the prediction of stability of benzoglycolamide ester prodrugs.

2006-08-01

[Chem. Pharm. Bull. 54(8) , 1067-71, (2006)]

More Articles...